The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species
J. Nysten, A. Peetermans, D. Vaneynde, L. Demuyser, P. Van Dijck
This paper identifies the riboflavin biosynthetic pathway as a novel antifungal target in Candida species, showing that key enzymes are essential and that riboflavin uptake mechanisms differ among species.
mBio · Nov 13, 2024Peer-reviewedMicrobiology